Claim being checked · Version 1 · Reviewed
“P21 has a proven safety profile in people.”
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Not established. The reviewed evidence does not establish this statement. This does not prove it can never be true.
Answer scope
This verdict checks the exact claim in the heading. It is not a universal grade for P21 peptide.
01 · Answer
Not established
The P021 registry search found no study in people. Animal studies cannot set a safe amount, rule out uncommon harm, or show long-term safety for people.
- What kind of evidence this is
- No reliable human outcome evidence. No reliable study in people shows the health outcome in this statement.
- What this answer covers
- People exposed to a verified P21 study product, with enough follow-up to assess harms. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
- Question type
- Safety. What is known and not known about harm, warnings, and safety limits.
02 · Sources
Read the sources behind this answer
01P21 learning, memory, and nerve-cell study in normal micePubMed · FEBS Letters · Preclinical · 2010
Defines the evidence limit02P021 tau study in aged ratsPubMed · Journal of Alzheimer’s Disease · Preclinical · 2015
Defines the evidence limit03Early P021 study in an Alzheimer-like mouse modelPubMed · Alzheimer’s Research & Therapy · Preclinical · 2017
Defines the evidence limit04ClinicalTrials.gov intervention search for P021ClinicalTrials.gov · Trial registry · 2026
Defines the evidence limit
Defines the evidence limit02P021 tau study in aged ratsPubMed · Journal of Alzheimer’s Disease · Preclinical · 2015
Defines the evidence limit03Early P021 study in an Alzheimer-like mouse modelPubMed · Alzheimer’s Research & Therapy · Preclinical · 2017
Defines the evidence limit04ClinicalTrials.gov intervention search for P021ClinicalTrials.gov · Trial registry · 2026
Defines the evidence limit
- Editorial review
- Internal editorial review recorded
- Source review
- Anthony Treviso · Founder and responsible editor
- Medical review status
- Not independently medically reviewed. Editorial source review does not replace medical review.